Tapping linked to function and structure in premanifest and symptomatic Huntington disease

Neurology

Volumn 75, Issue 24, 2010, Pages 2150-2160

  Bechtel, N ^a   Scahill, R I ^b   Rosas, H D ^c,d   Acharya, T ^e   Van Den Bogaard, S J A ^g   Jauffret, C ^h   Say, M J ^b   Sturrock, A ⁱ   Johnson, H ^e   Onorato, C E ^c   Salat, D H ^c   Durr, A ^h   Leavitt, B R ⁱ   Roos, R A C ^g   Landwehrmeyer, G B ^j   Langbehn, D R ^e,f   Stout, J C ^k   Tabrizi, S J ^b   Reilmann, R ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Department of Psychiatry ^*  (United States)

^f UNIVERSITY OF IOWA   (United States)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j UNIVERSITY OF ULM   (Germany)

^k MONASH UNIVERSITY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; CAG REPEAT; CONTROLLED STUDY; FORCE TRANSDUCER; GRAY MATTER; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; HYPOTHESIS; MAJOR CLINICAL STUDY; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; TASK PERFORMANCE; WHITE MATTER;

ADULT; AGE OF ONSET; ATROPHY; BIOMECHANICS; BRAIN; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DNA; FEMALE; HAND; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REPETITIVE SEQUENCES, NUCLEIC ACID; SEVERITY OF ILLNESS INDEX;

EID: 78650850960     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182020123     Document Type: Article

References (40)

1. Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 1994;44:823-828.
2. Rosas HD, Salat DH, Lee SY, et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008;131:1057-1068.
3. Reading SA, Yassa MA, Bakker A, et al. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study. Psychiatry Res 2005;140: 55-62.
4. Rosas HD, Tuch DS, Hevelone ND, et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord 2006;21:1317-1325.
5. Marder K, Zhao H, Myers RH, et al. Rate of functional decline in Huntington's disease: Huntington Study Group. Neurology 2000;54:452-458.
6. Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 2008; 79:874-880.
7. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791-801.
8. Kirkwood SC, Siemers E, Stout JC, et al. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 1999;56: 563-568.
9. Smith MA, Brandt J, Shadmehr R. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature 2000;403:544-549.
10. Andrich J, Saft C, Ostholt N, Muller T. Assessment of simple movements and progression of Huntington's disease. J Neurol Neurosurg Psychiatry 2007;78:405-407. (Pubitemid 46580553)
11. Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997;41:689-692.
12. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hay-den MR. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004;65:267-277.
13. Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979;29:1-3.
14. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113.
15. Solodkin A, Hlustik P, Noll DC, Small SL. Lateralization of motor circuits and handedness during finger movements. Eur J Neurol 2001;8:425-434.
16. Langbehn DR, Hayden MR, Paulsen JS. CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 2010;153B:397-408.
17. Ridgway GR, Omar R, Ourselin S, Hill DL, Warren JD, Fox NC. Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage 2009;44: 99-111.
18. Saft C, Andrich J, Meisel NM, Przuntek H, Muller T. Assessment of simple movements reflects impairment in Huntington's disease. Mov Disord 2006;21:1208-1212.
19. Michell AW, Goodman AO, Silva AH, Lazic SE, Morton AJ, Barker RA. Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington's disease. J Neurol 2008;255:1145-1152.
20. de Boo G, Tibben A, Hermans J, Maat A, Roos RA. Subtle involuntary movements are not reliable indicators of incipient Huntington's disease. Mov Disord 1998;13:96-99.
21. Hogarth P, Kayson E, Kieburtz K, et al. Interrater agreement in the assessment of motor manifestations of Hun-tington's disease. Mov Disord 2005;20:293-297.
22. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
23. Biglan KM, Ross CA, Langbehn DR, et al. Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov Disord 2009;24:1763-1772.
24. Gordon AM, Quinn L, Reilmann R, Marder K. Coordination of prehensile forces during precision grip in Hunting-ton's disease. Exp Neurol 2000;163:136-148.
25. Reilmann R, Kirsten F, Quinn L, Henningsen H, Marder K, Gordon AM. Objective assessment of progression in Huntington's disease: a 3-year follow-up study. Neurology 2001;57:920-924.
26. Rao AK, Muratori L, Louis ED, Moskowitz CB, Marder KS. Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease. Mov Disord 2008;23: 1100-1107.
27. Freeman JS, Cody FW, O'Boyle DJ, Craufurd D, Neary D, Snowden JS. Abnormalities of motor timing in Hun-tington's disease. Parkinsonism Relat Disord 1996;2: 81-93.
28. Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc 2007;13:539-543.
29. Hefter H, Homberg V, Lange HW, Freund HJ. Impairment of rapid movement in Huntington's disease. Brain 1987;110:585-612.
30. Beste C, Saft C, Andrich J, Muller T, Gold R, Falkenstein M. Time processing in Huntington's disease: a group-control study. PLoS One 2007;2:e1263.
31. Wolf RC, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer GB. Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp 2009;30:327-339.
32. Paulsen JS. Functional imaging in Huntington's disease. Exp Neurol 2009;216:272-277.
33. Bartenstein P, Weindl A, Spiegel S, et al. Central motor processing in Huntington's disease: a PET study. Brain 1997;120:1553-1567. (Pubitemid 27389223)
34. Colebatch JG, Deiber MP, Passingham RE, Friston KJ, Frackowiak RSJ. Regional cerebral blood flow during voluntary arm and hand movements in human subjects. J Neurophysiol 1991;65:1392-1401.
35. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ. Self-initiated versus externally triggered movements: I: an investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995;118:913-933.
36. Buhusi CV, Meck WH. What makes us tick? Functional and neural mechanisms of interval timing. Nat Rev Neu-rosci 2005;6:755-765.
37. Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex 2005;15:846-853.
38. Kloppel S, Draganski B, Siebner HR, Tabrizi SJ, Weiller C, Frackowiak RS. Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain 2009;132:1624-1632.
39. Paulsen JS, Zimbelman JL, Hinton SC, et al. fMRI bi-omarker of early neuronal dysfunction in presymptomatic Huntington's disease. AJNR Am J Neuroradiol 2004;25: 1715-1721.
40. Walhovd KB, Fjell AM. White matter volume predicts reaction time instability. Neuropsychologia 2007;45:2277-2284.